Drugs / Typhoid Vi vaccine
Typhoid Vi vaccine
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00125008 | May 2003 → Jan 2008 | paratyphoid fever, typhoid fever | International Vaccine Institute | Completed | Met primary |
| Phase 4 | NCT00131820 | Dec 2001 → Jan 2007 | paratyphoid fever, typhoid fever | International Vaccine Institute | Completed | No outcome recorded |
| Phase 4 | NCT00125047 | Oct 2001 → Aug 2007 | paratyphoid fever, typhoid fever | International Vaccine Institute | Completed | No outcome recorded |
| Phase 4 | NCT00131833 | Oct 2001 → Nov 2006 | paratyphoid fever, typhoid fever | International Vaccine Institute | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Typhoid Vi vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00131820 ↗ |
| Known as | Vi polysaccharide vaccine | “Uncertainties about the protective effect of Vi polysaccharide vaccine in children under the age of 5 years” PMID 19625715 ↗ Jul 2009 |
| Known as | Vi vaccine | “randomly assigned to receive a single dose of either Vi vaccine or inactivated hepatitis A vaccine” PMID 19625715 ↗ Jul 2009 |
| Modality | Vaccine | “Vi polysaccharide vaccine” NCT00125008 ↗ |